4//SEC Filing
Attar Eyal C. 4
Accession 0001415889-25-003734
CIK 0001817229other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 4:29 PM ET
Size
5.4 KB
Accession
0001415889-25-003734
Insider Transaction Report
Form 4
Attar Eyal C.
CHIEF MEDICAL OFFICER
Transactions
- Sale
Common Stock
2025-02-10$1.37/sh−2,554$3,499→ 128,852 total
Footnotes (2)
- [F1]The transaction was pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2024.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.33 to $1.42 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Vor Biopharma Inc.
CIK 0001817229
Entity typeother
Related Parties
1- filerCIK 0001789076
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 4:29 PM ET
- Size
- 5.4 KB